Loading...

Novartis AG

NVSEF•PNK
Healthcare
Drug Manufacturers - General
$145.00
$-0.03(-0.02%)
U.S. Market opens in 7h 53m

Novartis AG (NVSEF) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap276.7B
P/E Ratio19.73
EPS (TTM)$7.14
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$147.85
3 Months$178.42
1 Year Target$160.27

NVSEF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVSEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $160.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.73 and a market capitalization of 276.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.02%
5-Day Change
-0.35%
1-Month Change
-6.36%
3-Month Change
-4.61%
6-Month Change
13.45%
Year-to-Date (YTD) Change
5.07%
1-Year Change
30.15%
3-Year Change
41.88%
5-Year Change
67.40%
All-Time (Max) Change
260.25%

Contact Information

https://www.novartis.com
41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

75,883 Employees
IPO DateApr 26, 2010
CountryCH
Actively Trading

Frequently Asked Questions